Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Testing Content Uniformity of Cream Products in Process – V 2.0

Posted on By

Creams: SOP for Testing Content Uniformity of Cream Products in Process – V 2.0

Standard Operating Procedure for Testing Content Uniformity of Cream Products in Process

Department Creams
SOP No. SOP/CRM/169/2025
Supersedes SOP/CRM/169/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for testing content uniformity of cream products during the manufacturing process. Ensuring that the active ingredients and other components are evenly distributed throughout the batch is essential for product consistency, efficacy, and safety.

2. Scope

This SOP applies to the process of testing content uniformity during cream manufacturing. It covers sampling procedures, the testing methods for active ingredients, and the steps to ensure that the cream batch meets uniformity standards before progressing to the filling stage.

3. Responsibilities

  • Production Team: Responsible for providing cream samples at specified intervals during the production process to ensure uniform distribution of active ingredients.
  • Quality Control (QC) Team: Responsible for performing content uniformity tests, analyzing the results, and ensuring that the cream meets the required uniformity standards.
  • Laboratory Supervisor: Responsible for reviewing content uniformity test results and approving the batch for further processing if the test results meet specifications.
  • Maintenance
Team: Responsible for ensuring that equipment used for content uniformity testing is well-maintained and calibrated.

4. Accountability

The Production Manager is accountable for ensuring that content uniformity is tested as per this SOP. The QC Manager is responsible for overseeing the testing and ensuring that any deviations are addressed. The Laboratory Supervisor is accountable for reviewing the results and ensuring compliance with product specifications before the batch proceeds to filling.

5. Procedure

5.1 Pre-Testing Setup

  1. Ensure that the production process has reached the appropriate stage (typically after homogenization and before filling) to test the content uniformity of the cream batch.
  2. Verify that all equipment and instruments used for sampling and testing (e.g., sample containers, balances, HPLC equipment) are clean, calibrated, and functioning properly.
  3. Ensure that the sampling procedure and test methods for content uniformity are defined in the Batch Manufacturing Record (BMR) or product specifications.

5.2 Sampling Procedure

  1. Take representative samples of the cream at multiple points in the batch during the production process to ensure uniform distribution of the active ingredients. Samples should be taken from different locations (e.g., top, middle, bottom) within the batch container.
  2. Ensure that the sample volume is sufficient for the required tests (e.g., chemical analysis, active ingredient content, etc.).
  3. Label each sample with the batch number, sampling date, time, and other relevant details to maintain traceability.
  4. Transfer the samples to the QC laboratory immediately for testing, ensuring they are not exposed to temperature or environmental fluctuations.

5.3 Content Uniformity Testing

  1. Testing Method: Perform content uniformity tests using the appropriate method, such as High-Performance Liquid Chromatography (HPLC), spectrophotometry, or another validated method for measuring the active ingredient content in the cream.
  2. Uniformity Criteria: Ensure that the active ingredient content in all samples is within the acceptable range specified in the product specifications (usually ±10% of the label claim for cream products).
  3. Analysis: Analyze the test results to confirm that the cream batch is uniform in terms of active ingredient distribution. If any sample falls outside the acceptable range, a deviation procedure must be initiated.
  4. Record the test results in the Content Uniformity Log (Annexure-1), including details such as sample ID, test method, test results, and remarks.

5.4 Handling Deviations

  1. If any sample’s active ingredient content is outside the acceptable range, immediately document the deviation in the Deviation Report (Annexure-2).
  2. Investigate the cause of the deviation, which could include improper mixing, incorrect ingredient proportions, or equipment malfunction.
  3. Take corrective actions, which may include re-blending the batch, adjusting ingredient ratios, or reworking the batch if necessary.
  4. If the deviation is critical, halt the production process and evaluate whether the batch should be rejected or if further adjustments are needed before proceeding.
  5. Ensure that all deviations are thoroughly documented and reviewed by the QC and Laboratory Supervisors.

5.5 Post-Testing Activities

  1. Once the content uniformity tests are completed and the results are within the specified limits, approve the batch for the next stage (e.g., filling or packaging).
  2. If the batch passes the test, proceed with transferring the cream to the filling line for packaging.
  3. If the batch fails the test, reject the batch or initiate rework according to the Batch Rework SOP (SOP/CRM/004/2025).

5.6 Documentation and Record-Keeping

  1. Record all content uniformity testing data in the Content Uniformity Log (Annexure-1), including sample details, test results, and operator information.
  2. Document any deviations and corrective actions in the Deviation Report (Annexure-2), ensuring that all necessary details are captured.
  3. Maintain all records for a minimum of two years or as required by regulatory guidelines to ensure traceability and compliance during audits.
  4. Ensure that all records are reviewed and signed by the operator performing the test, the QC team, and the Laboratory Supervisor for verification and approval.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
  • PPE: Personal Protective Equipment
  • HPLC: High-Performance Liquid Chromatography

7. Documents

  1. Annexure-1: Content Uniformity Log
  2. Annexure-2: Deviation Report

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • FDA Guidance for Industry: Content Uniformity Testing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Content Uniformity Log

Batch Number Sample Location Test Method Test Result Operator Remarks
12345 Top HPLC Pass (±5%) John Doe Uniform distribution
12345 Middle HPLC Pass (±5%) Jane Smith Uniform distribution
12345 Bottom HPLC Pass (±5%) Michael Lee Uniform distribution

Annexure-2: Deviation Report

Batch Number Deviation Description Corrective Action Resolved By
12345 Content outside acceptable range Reworked formulation Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
See also  Creams: SOP for Handling and Storage of Machine Parts - V 2.0
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: Analytical Method Development: KBr Pellet Method Optimization – V 2.0
Next Post: Gel Manufacturing: SOP for Cleaning Labeling Equipment – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version